Pioneering contact lens approach slows myopia progression in children

We’re proud to be a part of the pioneering MiSight trial into shortsightedness in children and are delighted to bring you the four year findings, courtesy of CooperVision. The ongoing clinical trial is assessing a specially-designed, dual-focus myopia control 1-day soft contact lens in reducing the rate of progression of juvenile-onset myopia.

After four years, the study demonstrates that MiSight 1 day can significantly slow myopia progression and axial elongation compared with a single vision daily disposable lens.